Correlation Between NioCorp Developments and MIRA Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NioCorp Developments and MIRA Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NioCorp Developments and MIRA Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NioCorp Developments Ltd and MIRA Pharmaceuticals, Common, you can compare the effects of market volatilities on NioCorp Developments and MIRA Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NioCorp Developments with a short position of MIRA Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of NioCorp Developments and MIRA Pharmaceuticals,.

Diversification Opportunities for NioCorp Developments and MIRA Pharmaceuticals,

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between NioCorp and MIRA is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding NioCorp Developments Ltd and MIRA Pharmaceuticals, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MIRA Pharmaceuticals, and NioCorp Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NioCorp Developments Ltd are associated (or correlated) with MIRA Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MIRA Pharmaceuticals, has no effect on the direction of NioCorp Developments i.e., NioCorp Developments and MIRA Pharmaceuticals, go up and down completely randomly.

Pair Corralation between NioCorp Developments and MIRA Pharmaceuticals,

Allowing for the 90-day total investment horizon NioCorp Developments is expected to generate 1.28 times less return on investment than MIRA Pharmaceuticals,. But when comparing it to its historical volatility, NioCorp Developments Ltd is 2.08 times less risky than MIRA Pharmaceuticals,. It trades about 0.29 of its potential returns per unit of risk. MIRA Pharmaceuticals, Common is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  100.00  in MIRA Pharmaceuticals, Common on October 20, 2024 and sell it today you would earn a total of  21.00  from holding MIRA Pharmaceuticals, Common or generate 21.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NioCorp Developments Ltd  vs.  MIRA Pharmaceuticals, Common

 Performance 
       Timeline  
NioCorp Developments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NioCorp Developments Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
MIRA Pharmaceuticals, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MIRA Pharmaceuticals, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MIRA Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

NioCorp Developments and MIRA Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NioCorp Developments and MIRA Pharmaceuticals,

The main advantage of trading using opposite NioCorp Developments and MIRA Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NioCorp Developments position performs unexpectedly, MIRA Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will offset losses from the drop in MIRA Pharmaceuticals,'s long position.
The idea behind NioCorp Developments Ltd and MIRA Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets